New antibody combo takes on advanced solid tumors
Disease control
Recruiting now
This study tests a new drug called DT-7012, alone or with another cancer drug (an immune checkpoint inhibitor), in 125 adults with advanced solid tumors that have not responded to prior treatments. The goal is to see if the combination is safe and can shrink tumors. It is an earl…
Phase: PHASE1, PHASE2 • Sponsor: Domain Therapeutics Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC